Advertisement
Advertisement
U.S. Markets closed
Advertisement
Advertisement
Advertisement
Advertisement

Fate Therapeutics, Inc. (FATE)

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
36.06+2.24 (+6.62%)
At close: 04:00PM EDT
36.06 0.00 (0.00%)
After hours: 07:19PM EDT
Advertisement
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close33.82
Open33.44
Bid36.00 x 800
Ask36.07 x 1000
Day's Range33.01 - 36.75
52 Week Range17.10 - 91.90
Volume1,618,286
Avg. Volume1,575,261
Market Cap3.443B
Beta (5Y Monthly)1.58
PE Ratio (TTM)N/A
EPS (TTM)-2.12
Earnings DateFeb 22, 2022 - Feb 28, 2022
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est80.15
  • Motley Fool

    3 Cathie Wood Stocks for the Future

    Unlike a lot of tech investors, Cathie Wood is super bullish on biotechnology. Here are three of her picks that these Motley Fool contributors love.

  • GlobeNewswire

    Fate Therapeutics Announces Preclinical Publication Highlighting Derivation of CD8αβ T Cells from TCR-CAR+ Induced Pluripotent Stem Cells

    TCR-CAR+ iPSC-derived CD8αβ T Cells Induced Complete and Durable Responses In Vivo in Systemic Leukemia Model Cell-surface Markers, Gene Transcription Profile, and In Vivo Anti-tumor Activity of TCR-CAR+ iPSC-derived CD8αβ T Cells Compared Favorably with Healthy-donor Peripheral Blood CAR T Cells Phase 1 Study Ongoing of First-ever iPSC-derived T-cell Product Candidate FT819 for Off-the-shelf Treatment of Patients with Relapsed / Refractory B-cell Malignancies SAN DIEGO, Aug. 09, 2022 (GLOBE NEW

  • InvestorPlace

    7 Small-Cap Stocks to Buy Before the Bull Market Returns

    Small-cap stocks with lower market capitalizations ranging from $300 million to $2 billion have taken quite a hit since January. These stocks typically belong to smaller companies with massive long-term growth potential. However, they are sensitive to rising inflation and interest rate hikes due to tighter profits and weak balance sheets. Therefore these stocks have taken a bigger hit compared to the broader market. The Russell 2000’s performance is a testament to that, so it’s best to pick up s

Advertisement
Advertisement